| ²é¿´: 517 | »Ø¸´: 7 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
lassa½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
¹úÍâȨÍþÒ©¶¯Ñ§ÔÓÖ¾ÓÐÄÄЩ£¿
|
||
| ÈçÌâ¡£¹úÍâȨÍþÒ©¶¯Ñ§ÔÓÖ¾ÓÐÄÄЩ£¿ |
» ²ÂÄãϲ»¶
309Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856 | GPA 4.07 | ÓпÆÑоÀú
ÒѾÓÐ8È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Çó»¯Ñ§µ÷¼Á
ÒѾÓÐ5È˻ظ´
085600£¬²ÄÁÏÓ뻯¹¤321·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0703 »¯Ñ§ Çóµ÷¼Á£¬Ò»Ö¾Ô¸É½¶«´óѧ 342 ·Ö
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÄÏ¿ª´óѧ0710ÉúÎïѧ359Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬320·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏÓ뻯¹¤272Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
290Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
aihua315
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 27022.2
- É¢½ð: 28
- ºì»¨: 1
- Ìû×Ó: 3151
- ÔÚÏß: 867.2Сʱ
- ³æºÅ: 896540
- ×¢²á: 2009-11-07
- ÐÔ±ð: GG
- רҵ: ÖÐҩҩЧÎïÖÊ

8Â¥2009-12-12 18:29:42
¶À¹Â¾Ã½¡
ľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 1417
- ºì»¨: 37
- Ìû×Ó: 3327
- ÔÚÏß: 155Сʱ
- ³æºÅ: 330046
- ×¢²á: 2007-03-24
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
¡ï
karl2100(½ð±Ò+1,VIP+0):3Q 4-6 01:39
karl2100(½ð±Ò+1,VIP+0):3Q 4-6 01:39
|
ºÜ¶àµÄ¡£±ÈÈç Advanced Drug Delivery Reviews; Journal of Controlled Release; Pharmaceutical Research |

2Â¥2009-04-05 22:19:46
lassa
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 660.7
- Ìû×Ó: 198
- ÔÚÏß: 34.1Сʱ
- ³æºÅ: 291110
- ×¢²á: 2006-10-28
- רҵ: ½ðÈÚѧ
5Â¥2009-04-06 12:41:28
nyj1116
½ð³æ (СÓÐÃûÆø)
δÀ´¾«Ó¢
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 885.5
- É¢½ð: 75
- ºì»¨: 1
- Ìû×Ó: 293
- ÔÚÏß: 60.1Сʱ
- ³æºÅ: 728129
- ×¢²á: 2009-03-21
- רҵ: Ò©Îï·ÖÎö

6Â¥2009-04-13 21:59:47














»Ø¸´´ËÂ¥